BDNF and depressive disorder: These compounds not only induce rapid antidepressant-like effects in animal models of depression but also share many mechanisms of antidepressant activity with ketamine, including involvement of the BDNF and mTOR pathways and dependence on AMPA receptor activation and serotonergic system activity [8,9,10,11].